English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90452/105769 (86%)
Visitors : 11948374      Online Users : 407
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    ASIA unversity > 護理學院 > 護理學系 > 期刊論文 >  Item 310904400/110811


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/110811


    Title: Impact of Double Loading Regimen of Clopidogrel on FinalAngiographic Results, Incidence of Upper Gastrointestinal Bleeding and ClinicalOutcomes in Patients with STEMI Undergoing Primary Coronary Intervention.
    Authors: 鄭銘燊;Tong, Meng-Shen;宋沛勳;Sung, Pei-Hsun;柳居豐;Liu, Chu-Feng;陳冠宏;Chen, Kuan-Hung;鍾昇穎;Chung, Sheng-Ying;蔡慧玲;Chua, Sarah;Ch, Chien-Jen;Chen, Chien-Jen;李威杰;Lee, Wei-Chieh;柴漢東;Chai, Han-Tan;葉漢根;Yip, Hon-Kan;Ch, Hsueh-Wen;Chang, Hsueh-Wen
    Contributors: 護理學系
    Date: 2017-10
    Issue Date: 2018-04-03 09:51:09 (UTC+8)
    Abstract: This study tested the therapeutic impact of double-loading dose (i.e., 600 mg) versus standard-loading dose
    (i.e., 300 mg) of clopidogrel on ST-segment-elevation-myocardial-infarction (STEMI) patients undergoing
    primary-coronary-intervention (PCI).
    Between January 2005 and December 2013, a total of 1461 STEMI patients undergoing PCI were consecutively
    enrolled into the study and categorized into group 1 (600 mg/clopidogrel; n = 508) and group 2 (300 mg/
    clopidogrel; n = 953). We assessed angiographic thrombolysis-in-myocardial-infarction (TIMI) flow in the
    infarct-related-artery, 30-day mortality and upper-gastrointestinal-bleeding (UGIB) within 30 days as primaryendpoints
    and later incidents of UGIB as secondary-endpoints.
    The results showed that the incidences of advanced Killip score (defined as score 3) upon presentation
    (23.8% versus 24.6%) and advanced heart failure (defined as NYHAFc-3) (10.2% versus 10.4%) did not differ
    between groups 1 and 2 (all P > 0.4). Primary-endpoints, which were final TIM-3 flow (91.3% versus
    91.7%) in the infarct-related-artery, incidences of 30-day mortality (5.8% vs. 7.1%), and UGIB 30 day (7.8%
    versus 8.9%) did not differ between group 1 and group 2 (all P > 0.33). The secondary-endpoints which were
    incidences of 30-day < one-year (5.2% versus 4.7) and > one-year (8.9% versus 10.1%) UGIB did not differ
    between groups 1 and 2 (all P > 0.45). One-year mortality did not differ between two groups (10.74% versus
    12.9%) (P > 0.25). Multiple-stepwise-logistic-regression analysis showed that age and advanced-Killip score
    were independently predictive of 30-day mortality (all P < 0.001).
    Double-loading dose of clopidogrel did not confer an additional benefit to the final angiograph results, 30-
    day/one-year clinical outcomes; and age and advanced Killip-score were powerful predictors of 30-day mortality.
    Relation: International Heart Journal
    Appears in Collections:[護理學系] 期刊論文

    Files in This Item:

    File SizeFormat
    index.html0KbHTML120View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback